Balance sheet of Beta Drugs is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Beta Drugs is increasing.
Latest debt of Beta Drugs is -₹17.64 Crs as of Mar-24.
This is greater than Mar-23 when it was -₹17.65 Crs.

Yes, profit is increasing.
The profit of Beta Drugs is ₹36.44 Crs for TTM, ₹30.72 Crs for Mar 2023 and ₹24.83 Crs for Mar 2022.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Beta Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable